The FDA’s regulation of the CBD market has taken its toll on a heavy hitter in the marketplace. Curaleaf, which is sold in CVS Health stores, was issued a warning letter from the Food and Drug Administration over health claims made by the company. According to CBS News, Curaleaf is working to remedy issues raised in the FDA…

Redefining Medication While in Line with the TSA Your bags are packed, you’re ready to go, you’re standing here outside TSA, You’d hate to wind up with a criminal record… Did you pack medication? Will they land you in federal prison? Is your pill box TSA approved? Because you’re leaving on a jet plane, don’t…

With the Passage of the 2018 Farm Bill, states are scrambling to update their Hemp Pilot Programs and replace them with permanent hemp laws and regulation. Washington State is no exception. On January 16, Senate Bill 5276 (officially titled “Authorizing hemp production in conformance with the agricultural improvement act of 2018”) was introduced. In its…

In recent years, the legal status of marijuana, CBD, and hemp have been common topics of discussion on the local, national, and international scale. As legalization in its many forms has spread in the United States, the conversation around cannabis and its effects has become more nuanced and commonplace. Recently, cannabinoid research company Verda Bio…

Neil Juneja featured on Cannabis Industry Podcast Last week, School for Startups Radio interviewed Neil Juneja about his experience in the legal cannabis industry. In the episode, Neil talks about the difference between recreational and medical cannabis, and what the implications are for the medical industry in states  that legalize medical and recreational marijuana. He…

California Department of Public Health Prohibits CBD in Food Products By Orion Inskip, Attorney at Gleam Law PLLC According to a recent FAQ released by the California Department of Public Health’s Food & Drug Branch (CDPH-FDB), CBD is prohibited from use in any food product sold outside of the legal cannabis industry in the state….

BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana Written by Orion Inskip, Attorney at Gleam Law, PLLC.  The Food and Drug Administration (FDA) has approved Epidiolex, an epilepsy medicine derived from marijuana. The drug’s active ingredient is a non-psychoactive cannabinoid known as cannabidiol (CBD) and is the first marijuana-based medication approved by the FDA. This…

Written by Orion Inskip, Attorney at Gleam Law, PLLC. Cannabis laws are rapidly evolving across the world. This has been no less true when it comes to cannabidiol, more popularly known as CBD. CBD is a naturally occurring compound found in cannabis that does not have the psychoactive effect typically associated with marijuana, which is…

The FDA recently sent warning letters two four CBD companies. Written by Orion Inskip, Attorney at Gleam Law, PLLC.  The Federal Drug Administration (FDA) regulates medicine throughout the United States.  Their power flows from the  Federal Food, Drug, and Cosmetic Act (FDCA), enacted by Congress in 1938. Under the FDCA companies cannot advertise that a drug will…

Cannabis Business struggle To Trademark With USPTO No Trademarks for Cannabis? Not quite – Protecting your trademark is one of the most important things a new business can do. Every minute you spend on marketing increases your brand’s value, value that could be stolen by some competitor who starts using a confusingly similar name, logo,…